Add to ORKGThe prevalence of venous thromboembolism (VTE) in ovarian cancer during first-line chemotherapy (CHT) ranges between 6.4% and 10.6%. Identification of the susceptible population is crucial for effective thromboprophylaxis.Age, BMI, and stage permit to identify ovarian cancer patients with a high risk in developing symptomatic VTE during CHT
BACKGROUND. Venous thromboembolism (VTE) is associated with ovarian cancer and may impact the progno...
Breast cancer patients are at increased risk of VTE, particularly in the peri-diagnosis period. Howe...
The incidence of venous thromboembolism (VTE) in cancer patients may have changed in the past decade...
ObjectivesTo determine the impact of venous thromboembolism (VTE) during primary treatment of ovaria...
Venous thromboembolism in cancer patients undertaking chemotherapy ii Background Venous thromboembol...
Background Venous thromboembolism (VTE) is an umbrella term for the pathological development of b...
To profile the characteristic and prognostic implications of venous thromboembolism (VTE) in Chinese...
Objective: Venous thromboembolism (VTE) is a life-threatening complication that often occurs in ovar...
Background The incidence of venous thromboembolism (VTE) is 1-2/1000 individuals. Patients with canc...
Background: Thrombotic events are common in cancer patients and have been associated with an adverse...
Background: The occurrence of a venous thromboembolism (VTE) is common in patients with cancer. Gast...
<p>Abbreviations: VTE, venous thromboembolism; DVT, deep vein thrombosis; PE, pulmonary embolism.</p...
Patients with breast cancer are at increased risk of venous thromboembolism (VTE), particularly in t...
International audienceVenous thromboembolism (VTE) is a major common complication in cancer patients...
BACKGROUNDRisk factors for cancer-associated VTE include certain cancer types (e.g. pancreatic adeno...
BACKGROUND. Venous thromboembolism (VTE) is associated with ovarian cancer and may impact the progno...
Breast cancer patients are at increased risk of VTE, particularly in the peri-diagnosis period. Howe...
The incidence of venous thromboembolism (VTE) in cancer patients may have changed in the past decade...
ObjectivesTo determine the impact of venous thromboembolism (VTE) during primary treatment of ovaria...
Venous thromboembolism in cancer patients undertaking chemotherapy ii Background Venous thromboembol...
Background Venous thromboembolism (VTE) is an umbrella term for the pathological development of b...
To profile the characteristic and prognostic implications of venous thromboembolism (VTE) in Chinese...
Objective: Venous thromboembolism (VTE) is a life-threatening complication that often occurs in ovar...
Background The incidence of venous thromboembolism (VTE) is 1-2/1000 individuals. Patients with canc...
Background: Thrombotic events are common in cancer patients and have been associated with an adverse...
Background: The occurrence of a venous thromboembolism (VTE) is common in patients with cancer. Gast...
<p>Abbreviations: VTE, venous thromboembolism; DVT, deep vein thrombosis; PE, pulmonary embolism.</p...
Patients with breast cancer are at increased risk of venous thromboembolism (VTE), particularly in t...
International audienceVenous thromboembolism (VTE) is a major common complication in cancer patients...
BACKGROUNDRisk factors for cancer-associated VTE include certain cancer types (e.g. pancreatic adeno...
BACKGROUND. Venous thromboembolism (VTE) is associated with ovarian cancer and may impact the progno...
Breast cancer patients are at increased risk of VTE, particularly in the peri-diagnosis period. Howe...
The incidence of venous thromboembolism (VTE) in cancer patients may have changed in the past decade...